Cost-effectiveness analysis of three therapeutics schemes for chronic pelvic inflammatory disease

Objective To evaluate the economic efficacy of three therapeutic schemes for chronic pelvic inflammatory disease.Methods A total of 126 patients with chronic pelvic inflammatory disease were randomly divided into 3 groups:Group A was assigned to receive Nuan-gong-tie combined with metronidarole and dexamethasone for enem (Scheme A);Group B to receive Microwave plus metronidazole and dexamethasone for enem (Scheme B);Group C to receive Ampieillin and metronidazol for intervenous drop infusion (Scheme C).Evaluate the economic efficacy of these three therapeutic schemes by costeffectiveness analysis.Results The costs of these three groups were 400 yuan,365 yuan and 169 yuan respectively.The total effeetive rates of these three groups were 81.8%,60% and 30.8% respectively.And the cost-effectiveness ratios were.4.89,6.08 and 5.48 respectively.Cost-effectiveness ratios by sensitivity analysis of 3 schemes were 4.8,6.84 and 5.10 respectively.Conclusions The Seheme A manifests significant economic superiority. Key words: Chronic pelvic inflammatory disease;  Nuan-gong-tie;  Cost-effectiveness analysis